Who are Contera Pharma's investors?

Contera Pharma's investors include SEED Capital Denmark.

Where is Contera Pharma headquartered?

Contera Pharma is headquartered in Copenhagen, DK.

Contera Pharma

Copenhagen, DK · 1 known investors

Bukwang Pharm is a South Korean pharmaceutical company that develops and licenses drugs for antiviral, gastrointestinal, CNS, and metabolic disorders. The company sells primarily licensed products from Europe, the United States, and Japan.

BiotechDigital HealthMedical Devices

Founders & leadership

Thomas SagerCEO

Investors · 1

SEED Capital DenmarkCopenhagen · $2.1M – $4.3M

Competitors · 1

by search overlap

Fronteratherapeutics3 shared keywordsFrontera Therapeutics is a clinical-stage gene therapy company developing treatments for large-market and rare diseases across ophthalmology, cardiology, and neurology. Several of its programs, targeting conditions such as inherited retinal diseases, nAMD, and cardiomyopathies, have entered or completed Phase II clinical trials.

Companies competing with Contera Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Contera Pharma do?: Bukwang Pharm is a South Korean pharmaceutical company that develops and licenses drugs for antiviral, gastrointestinal, CNS, and metabolic disorders. The company sells primarily licensed products from Europe, the United States, and Japan.
Who are Contera Pharma's investors?: Contera Pharma's investors include SEED Capital Denmark.
Where is Contera Pharma headquartered?: Contera Pharma is headquartered in Copenhagen, DK.